Cargando…

Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)

AIMS/HYPOTHESIS: The aim of the study was to determine the transition rate and factors associated with the progression of normo- and low microalbuminuria to diabetic nephropathy (overt proteinuria). METHODS: For 8 years we prospectively observed 1,558 Japanese patients with type 2 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, S., Moriya, T., Tanaka, S., Yajima, Y., Sone, H., Iimuro, S., Ohashi, Y., Akanuma, Y., Yamada, N.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071947/
https://www.ncbi.nlm.nih.gov/pubmed/21286682
http://dx.doi.org/10.1007/s00125-010-2025-0
_version_ 1782201491016122368
author Katayama, S.
Moriya, T.
Tanaka, S.
Tanaka, S.
Yajima, Y.
Sone, H.
Iimuro, S.
Ohashi, Y.
Akanuma, Y.
Yamada, N.
author_facet Katayama, S.
Moriya, T.
Tanaka, S.
Tanaka, S.
Yajima, Y.
Sone, H.
Iimuro, S.
Ohashi, Y.
Akanuma, Y.
Yamada, N.
author_sort Katayama, S.
collection PubMed
description AIMS/HYPOTHESIS: The aim of the study was to determine the transition rate and factors associated with the progression of normo- and low microalbuminuria to diabetic nephropathy (overt proteinuria). METHODS: For 8 years we prospectively observed 1,558 Japanese patients with type 2 diabetes mellitus whose basal urinary albumin:creatinine ratio (UACR) had been measured as <17.0 mg/mmol at entry. The incidence of nephropathy (UACR >33.9 mg/mmol) was determined by measuring UACR twice a year. RESULTS: Progression to nephropathy occurred in 74 patients. The annual transition rate was 0.67%, and was substantially higher for the low-microalbuminuric group than for the normoalbuminuric group (1.85% and 0.23%, respectively; hazard ratio for the low-microalbuminuric group 8.45, p < 0.01). The hazard ratio for an HbA(1c) of 7–9% or ≥9% was 2.72 (p < 0.01) or 5.81 (p < 0.01) relative to HbA(1c) <7.0%, respectively. In comparison with individuals with a systolic blood pressure (SBP) of <120 mmHg, the hazard ratios for patients with an SBP of 120–140 mmHg or ≥140 mmHg were 2.31 (p = 0.06) and 3.54 (p < 0.01), respectively. Smoking also affected progression to proteinuria (hazard ratio 1.99, p < 0.01). In contrast, 30.3% of the low-microalbuminuric group returned to normoalbuminuria (i.e. were in remission). CONCLUSIONS/INTERPRETATION: These results suggest that if patients with type 2 diabetes mellitus are receiving treatment from diabetologists for hyperglycaemia and hypertension when they are in the early stages of nephropathy (i.e. normo- or low microalbuminuria), their rate of transition to proteinuria is considerably lowered, and that differentiating patients with low microalbuminuria from those with high microalbuminuria might be clinically useful. TRIAL REGISTRATION: UMIN Clinical Trials Registry C000000222 FUNDING: The study was funded by the Ministry of Health, Labour and Welfare, Japan. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-2025-0) contains supplementary material, which is available to authorised users.
format Text
id pubmed-3071947
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30719472011-05-18 Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS) Katayama, S. Moriya, T. Tanaka, S. Tanaka, S. Yajima, Y. Sone, H. Iimuro, S. Ohashi, Y. Akanuma, Y. Yamada, N. Diabetologia Article AIMS/HYPOTHESIS: The aim of the study was to determine the transition rate and factors associated with the progression of normo- and low microalbuminuria to diabetic nephropathy (overt proteinuria). METHODS: For 8 years we prospectively observed 1,558 Japanese patients with type 2 diabetes mellitus whose basal urinary albumin:creatinine ratio (UACR) had been measured as <17.0 mg/mmol at entry. The incidence of nephropathy (UACR >33.9 mg/mmol) was determined by measuring UACR twice a year. RESULTS: Progression to nephropathy occurred in 74 patients. The annual transition rate was 0.67%, and was substantially higher for the low-microalbuminuric group than for the normoalbuminuric group (1.85% and 0.23%, respectively; hazard ratio for the low-microalbuminuric group 8.45, p < 0.01). The hazard ratio for an HbA(1c) of 7–9% or ≥9% was 2.72 (p < 0.01) or 5.81 (p < 0.01) relative to HbA(1c) <7.0%, respectively. In comparison with individuals with a systolic blood pressure (SBP) of <120 mmHg, the hazard ratios for patients with an SBP of 120–140 mmHg or ≥140 mmHg were 2.31 (p = 0.06) and 3.54 (p < 0.01), respectively. Smoking also affected progression to proteinuria (hazard ratio 1.99, p < 0.01). In contrast, 30.3% of the low-microalbuminuric group returned to normoalbuminuria (i.e. were in remission). CONCLUSIONS/INTERPRETATION: These results suggest that if patients with type 2 diabetes mellitus are receiving treatment from diabetologists for hyperglycaemia and hypertension when they are in the early stages of nephropathy (i.e. normo- or low microalbuminuria), their rate of transition to proteinuria is considerably lowered, and that differentiating patients with low microalbuminuria from those with high microalbuminuria might be clinically useful. TRIAL REGISTRATION: UMIN Clinical Trials Registry C000000222 FUNDING: The study was funded by the Ministry of Health, Labour and Welfare, Japan. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-2025-0) contains supplementary material, which is available to authorised users. Springer-Verlag 2011-02-01 2011 /pmc/articles/PMC3071947/ /pubmed/21286682 http://dx.doi.org/10.1007/s00125-010-2025-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Katayama, S.
Moriya, T.
Tanaka, S.
Tanaka, S.
Yajima, Y.
Sone, H.
Iimuro, S.
Ohashi, Y.
Akanuma, Y.
Yamada, N.
Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
title Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
title_full Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
title_fullStr Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
title_full_unstemmed Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
title_short Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS)
title_sort low transition rate from normo- and low microalbuminuria to proteinuria in japanese type 2 diabetic individuals: the japan diabetes complications study (jdcs)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071947/
https://www.ncbi.nlm.nih.gov/pubmed/21286682
http://dx.doi.org/10.1007/s00125-010-2025-0
work_keys_str_mv AT katayamas lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT moriyat lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT tanakas lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT tanakas lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT yajimay lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT soneh lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT iimuros lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT ohashiy lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT akanumay lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT yamadan lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs
AT lowtransitionratefromnormoandlowmicroalbuminuriatoproteinuriainjapanesetype2diabeticindividualsthejapandiabetescomplicationsstudyjdcs